ONC Latest Headlines

BeOne Medicines Ltd (6160) Gets a Buy from Nomura

at www.tipranks.com (Mon, 27-Jul 8:35 PM)

BeOne Medicines Ltd (6160) Receives a Buy from UBS

at www.tipranks.com (Fri, 24-Jul 8:25 PM)

Morgan Stanley Reaffirms Their Buy Rating on BeOne Medicines (ONC)

at www.tipranks.com (Thu, 23-Jul 9:05 AM)

BeOne expands U.S. footprint with $300M investment in New Jersey

at seekingalpha.com (Thu, 23-Jul 8:37 AM)

BRUKINSA Plus Rituximab Shown to Reduce Risk of Progression or Death by 43% in Frontline Mantle Cell Lymphoma—Chemotherapy-Free Regimen Meets Key Phase 3 Endpoint

Market Chameleon (Tue, 30-Jun 7:09 AM)

ONC's Phase 3 HERIZON-GEA Study Shows Seven-Month Survival Gain in HER2+ Gastroesophageal Cancer

Market Chameleon (Thu, 28-May 7:08 AM)

BeOne Medicines Showcases Over 60 Abstracts at ASCO and EHA 2026, Cementing Leadership in CLL and Expanding its Solid Tumor Pipeline

Market Chameleon (Thu, 21-May 7:10 AM)